John W. Higuchi
John W. Higuchi has made 2 open-market purchases worth $82k since Oct 1, 2026, in 1 company. The latest: $55k of LPCN, filed Oct 2, 2026, scored 31 out of 100.
Director, Lipocine Inc.
Follow John W. Higuchi, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 2 Form 4 (opens sec.gov) |
LPCNLipocine Inc. · DirectorDirector · Near 52-week low | +12% stake | 31 | $55k 25,007 at $2.20 |
−16.1% | waiting |
| Oct 1 Form 4 (opens sec.gov) |
LPCNLipocine Inc. · DirectorDirector · Near 52-week low | +6% stake | 26 | $27k 12,561 at $2.16 |
−6.8% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −11.4% (0% up, 2 measured).
Questions
What stock has John W. Higuchi bought?
LPCN (Lipocine Inc.), all on the open market and reported on SEC Form 4.
When did John W. Higuchi last buy?
Oct 2, 2026: 25,007 shares of LPCN at $2.20, $55k in all (Form 4 (opens sec.gov)).
Has John W. Higuchi filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is John W. Higuchi a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 2, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer